Effects of angiotensin II type 1 receptor blocker on albumin-induced cell damage in human renal proximal tubular epithelial cells

American Journal of Nephrology

Volumn 29, Issue 2, 2009, Pages 102-108

  Takao, Toshihiro ^a,b   Horino, Taro ^b   Kagawa, Toru ^b   Matsumoto, Reiko ^b   Inoue, Kousuke ^b   Taguchi, Takafumi ^b   Morita, Tatsuhito ^b   Iwasaki, Yasumasa ^b   Hashimoto, Kozo ^b   Terada, Yoshio ^b  

^a Department of Community Nursing

^b KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

8 Hydroxy 2 deoxyguanosine; Angiotensin II type 1 receptor blockers; Human renal proximal tubular epithelial cells; N acetyl D glucosaminidase; p22phox protein

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ALBUMIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN II; BETA N ACETYLGALACTOSAMINIDASE; OLMESARTAN; PROTEIN P22; VALSARTAN;

ARTICLE; CELL DAMAGE; CELL LYSATE; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; HUMAN; HUMAN CELL; KIDNEY EPITHELIUM; KIDNEY PROXIMAL TUBULE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEINURIA; WESTERN BLOTTING;

ACETYLGLUCOSAMINIDASE; ALBUMINS; ALBUMINURIA; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; CELLS, CULTURED; DEOXYGUANOSINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMIDAZOLES; KIDNEY TUBULES, PROXIMAL; NADPH OXIDASE; OXIDATIVE STRESS; TETRAZOLES; VALINE;

EID: 48749117993     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000151294     Document Type: Article

References (28)

1. Wolf G, Schroeder R, Ziyadeh FN, Stahl RA: Albumin up-regulates the type II transforming growth factor-beta receptor in cultured proximal tubular cells. Kidney Int 2004;66:1849-1858.
2. Burton C, Harris KP: The role of proteinuria in the progression of chronic renal failure. Am J Kidney Dis 1996;27:765-775.
3. Remuzzi G, Ruggenenti P, Benigni A: Understanding the nature of renal disease progression. Kidney Int 1997;51:2-15.
4. Benigni A, Zoja C, Remuzzi G: The renal toxicity of sustained glomerular protein traffic. Lab Invest 1995;73:461-468.
5. D'Amico G, Ferrario F, Rastaldi MP: Tubulointerstitial damage in glomerular diseases: its role in the progression of renal damage. Am J Kidney Dis 1995;26:124-132.
6. Le Hir M, Dubach UC, Schmidt U: Quantitative distribution of lysosomal hydrolases in the rat nephron. Histochemistry 1979;63:245-251.
7. Goto M, Mizunashi K: Calcitonin stimulates lysosomal enzyme release and uptake in LLC-PK1 cells. J Am Soc Nephrol 1999;10:1640-1648.
8. Bazzi C, Petrini C, Rizza V, Arrigo G, Napodano P, Paparella M, D'Amico G: Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis. Nephrol Dial Transplant 2002;17:1890-1896.
9. Whaley-Connell AT, Morris EM, Rehmer N, Yaghoubian JC, Wei Y, Hayden MR, Habibi J, Stump CS, Sowers JR: Albumin activation of NAD(P)H oxidase activity is mediated via Rac1 in proximal tubule cells. Am J Nephrol 2007;27:15-23.
10. Nakajima H, Takenaka M, Kaimori JY, Hamano T, Iwatani H, Sugaya T, Ito T, Hori M, Imai E: Activation of the signal transducer and activator of transcription signaling pathway in renal proximal tubular cells by albumin. J Am Soc Nephrol 2004;15:276-285.
11. Shalamanova L, McArdle F, Amara AB, Jackson MJ, Rustom R: Albumin overload induces adaptive responses in human proximal tubular cells through oxidative stress but not via angiotensin II type 1 receptor. Am J Physiol Renal Physiol 2007;292:F1846-F1857.
12. Sonta T, Inoguchi T, Matsumoto S, Yasukawa K, Inuo M, Tsubouchi H, Sonoda N, Kobayashi K, Utsumi H, Nawata H: In vivo imaging of oxidative stress in the kidney of diabetic mice and its normalization by angiotensin II type 1 receptor blocker. Biochem Biophys Res Commun 2005;330:415-422.
13. Blantz RC, Wilson CB, Gabbai FB: Pathophysiology of acute glomerular injury;in Neilson EG, Couser WG (eds): Immunologic Renal Diseases. Philadelphia, Lippincott-Raven Publishers, 1997, pp 237-250.
14. + exchanger 3 in OKP cells. J Am Soc Nephrol 2003;14:3008-3016.
15. Morais C, Westhuyzen J, Metharom P, Healy H: High molecular weight plasma proteins induce apoptosis and Fas/FasL expression in human proximal tubular cells. Nephrol Dial Transplant 2005;20:50-58.
16. Fujii S, Zhang L, Kosaka H: Albuminuria, expression of nicotinamide adenine dinucleotide phosphate oxidase and monocyte chemoattractant protein-1 in the renal tubules of hypertensive Dahl salt-sensitive rats. Hypertens Res 2007;30:991-998.
17. Leusen JH, Verhoeven AJ, Roos D: Interactions between the components of the human NADPH oxidase: a review about the intrigues in the phox family. Front Biosci 1996;1:d72-d90.
18. Yoo CW, Song CY, Kim BC, Hong HK, Lee HS: Glycated albumin induces superoxide generation in mesangial cells. Cell Physiol Biochem 2004;14:361-368.
19. Sirker A, Zhang M, Murdoch C, Shah AM: Involvement of NADPH oxidases in cardiac remodelling and heart failure. Am J Nephrol 2007;27:649-660.
20. Ishola DA Jr, Post JA, van Timmeren MM, Bakker SJ, Goldschmeding R, Koomans HA, Braam B, Joles JA: Albumin-bound fatty acids induce mitochondrial oxidant stress and impair antioxidant responses in proximal tubular cells. Kidney Int 2006;70:724-731.
21. Satoh M, Kashihara N, Fujimoto S, Horike H, Tokura T, Namikoshi T, Sasaki T, Makino H: A novel free radical scavenger, edarabone, protects against cisplatin-induced acute renal damage in vitro and in vivo. J Pharmacol Exp Ther 2003;305:1183-1190.
22. Mizuno M, Sada T, Kato M, Koike H: Renoprotective effects of blockade of angiotensin II AT1 receptors in an animal model of type 2 diabetes. Hypertens Res 2002;25:271-278.
23. Ogawa S, Mori T, Nako K, Kato T, Takeuchi K, Ito S: Angiotensin II type 1 receptor blockers reduce urinary oxidative stress markers in hypertensive diabetic nephropathy. Hypertension 2006;47:699-705.
24. Izuhara Y, Nangaku M, Inagi R, Tominaga N, Aizawa T, Kurokawa K, van Ypersele de Strihou C, Miyata T: Renoprotective properties of angiotensin receptor blockers beyond blood pressure lowering. J Am Soc Nephrol 2005;16:3631-3641.
25. Kadowaki D, Anraku M, Tasaki Y, Kitamura K, Wakamatsu S, Tomita K, Gebicki JM, Maruyama T, Otagiri M: Effect of olmesartan on oxidative stress in hemodialysis patients. Hypertens Res 2007;30:395-402.
26. Onozato ML, Tojo A, Goto A, Fujita T, Wilcox CS: Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB. Kidney Int 2002;61:186-194.
27. Shao J, Nangaku M, Inagi R, Kato H, Miyata T, Matsusaka T, Noiri E, Fujita T: Receptor-independent intracellular radical scavenging activity of an angiotensin II receptor blocker. J Hypertens 2007;25:1643-1649.
28. Miyata T, van Ypersele de Strihou C, Ueda Y, Ichimori K, Inagi R, Onogi H, Ishikawa N, Nangaku M, Kurokawa K: Angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: biochemical mechanisms. J Am Soc Nephrol 2002;13:2478-2487.